FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081875170> ?p ?o ?g. }

• W3081875170 endingPage "7829" @default.
• W3081875170 startingPage "7819" @default.
• W3081875170 abstract "Background Autologous stem cell transplantation (ASCT) has been recommended as a standard approach for young multiple myeloma (MM) patients for decades, even in the era of novel agents. Gain of chromosome 1q21 is a common cytogenetic abnormality in MM, while its clinical prognostic value is still controversial. Methods In this multicenter study, we retrospectively analyzed 1q21 gain in 446 newly diagnosed MM patients who received at least one ASCT from three large myeloma centers in China. Results Of the all 446 patients, 1q21 gain was an adverse predictor of progression-free survival (PFS) (34 vs 56 months, P = .005) and overall survival (OS) (69 vs 100 months, P = .002). Gain of 1q21 was more likely to coexist with t(4;14), t(14;16), and del(13q). Nevertheless, isolated 1q21 gain still exhibited unfavorable effects on PFS (35 vs 66 months, P = .045) and OS (61 vs 100 months, P = .026). The coexistence of 1q21 gain and high-risk cytogenetics (HRCs) [del(17p), t(4;14),and/or t(14;16)] showed poor prognosis on both PFS and OS, while no additional adverse effect could be identified when compared with HRCs alone. Moreover, when coexisting with t(11;14), patients with 1q21 gain showed a comparable survival to those without 1q21 gain. For patients treated with novel induction regimens followed by ASCT, 1q21 gain also conferred an inferior prognosis. Multivariate analysis further confirmed 1q21 gain could independently predict shorter PFS and OS. Conclusion In conclusion, 1q21 gain is an adverse prognostic factor for MM patients received ASCT." @default.
• W3081875170 created "2020-09-08" @default.
• W3081875170 creator A5005926303 @default.
• W3081875170 creator A5007918845 @default.
• W3081875170 creator A5015870868 @default.
• W3081875170 creator A5018889104 @default.
• W3081875170 creator A5021624950 @default.
• W3081875170 creator A5031186378 @default.
• W3081875170 creator A5032287053 @default.
• W3081875170 creator A5036587437 @default.
• W3081875170 creator A5039117319 @default.
• W3081875170 creator A5046375479 @default.
• W3081875170 creator A5056253982 @default.
• W3081875170 creator A5073708614 @default.
• W3081875170 creator A5083332923 @default.
• W3081875170 creator A5087171601 @default.
• W3081875170 date "2020-09-02" @default.
• W3081875170 modified "2023-10-15" @default.
• W3081875170 title "Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China" @default.
• W3081875170 cites W2037050131 @default.
• W3081875170 cites W2044436186 @default.
• W3081875170 cites W2046408556 @default.
• W3081875170 cites W2049932140 @default.
• W3081875170 cites W2056206654 @default.
• W3081875170 cites W2060119797 @default.
• W3081875170 cites W2086862058 @default.
• W3081875170 cites W2087843841 @default.
• W3081875170 cites W2089107230 @default.
• W3081875170 cites W2110648338 @default.
• W3081875170 cites W2115385885 @default.
• W3081875170 cites W2128192762 @default.
• W3081875170 cites W2131837746 @default.
• W3081875170 cites W2140568894 @default.
• W3081875170 cites W2150101334 @default.
• W3081875170 cites W2164807675 @default.
• W3081875170 cites W2212499331 @default.
• W3081875170 cites W2318069817 @default.
• W3081875170 cites W2320540304 @default.
• W3081875170 cites W2355678776 @default.
• W3081875170 cites W2511571730 @default.
• W3081875170 cites W2520654044 @default.
• W3081875170 cites W2572867610 @default.
• W3081875170 cites W2604776612 @default.
• W3081875170 cites W2622796688 @default.
• W3081875170 cites W2731928209 @default.
• W3081875170 cites W2793143141 @default.
• W3081875170 cites W2809698015 @default.
• W3081875170 cites W2819082975 @default.
• W3081875170 cites W2970385509 @default.
• W3081875170 cites W2990865799 @default.
• W3081875170 cites W4211058750 @default.
• W3081875170 cites W4211114373 @default.
• W3081875170 doi "https://doi.org/10.1002/cam4.3254" @default.
• W3081875170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7643680" @default.
• W3081875170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32881351" @default.
• W3081875170 hasPublicationYear "2020" @default.
• W3081875170 type Work @default.
• W3081875170 sameAs 3081875170 @default.
• W3081875170 citedByCount "7" @default.
• W3081875170 countsByYear W30818751702021 @default.
• W3081875170 countsByYear W30818751702022 @default.
• W3081875170 countsByYear W30818751702023 @default.
• W3081875170 crossrefType "journal-article" @default.
• W3081875170 hasAuthorship W3081875170A5005926303 @default.
• W3081875170 hasAuthorship W3081875170A5007918845 @default.
• W3081875170 hasAuthorship W3081875170A5015870868 @default.
• W3081875170 hasAuthorship W3081875170A5018889104 @default.
• W3081875170 hasAuthorship W3081875170A5021624950 @default.
• W3081875170 hasAuthorship W3081875170A5031186378 @default.
• W3081875170 hasAuthorship W3081875170A5032287053 @default.
• W3081875170 hasAuthorship W3081875170A5036587437 @default.
• W3081875170 hasAuthorship W3081875170A5039117319 @default.
• W3081875170 hasAuthorship W3081875170A5046375479 @default.
• W3081875170 hasAuthorship W3081875170A5056253982 @default.
• W3081875170 hasAuthorship W3081875170A5073708614 @default.
• W3081875170 hasAuthorship W3081875170A5083332923 @default.
• W3081875170 hasAuthorship W3081875170A5087171601 @default.
• W3081875170 hasBestOaLocation W30818751701 @default.
• W3081875170 hasConcept C126322002 @default.
• W3081875170 hasConcept C143998085 @default.
• W3081875170 hasConcept C168563851 @default.
• W3081875170 hasConcept C17744445 @default.
• W3081875170 hasConcept C191935318 @default.
• W3081875170 hasConcept C197934379 @default.
• W3081875170 hasConcept C199539241 @default.
• W3081875170 hasConcept C2776364478 @default.
• W3081875170 hasConcept C2779050716 @default.
• W3081875170 hasConcept C28328180 @default.
• W3081875170 hasConcept C2911091166 @default.
• W3081875170 hasConcept C2992435398 @default.
• W3081875170 hasConcept C54355233 @default.
• W3081875170 hasConcept C71924100 @default.
• W3081875170 hasConcept C86803240 @default.
• W3081875170 hasConceptScore W3081875170C126322002 @default.
• W3081875170 hasConceptScore W3081875170C143998085 @default.
• W3081875170 hasConceptScore W3081875170C168563851 @default.
• W3081875170 hasConceptScore W3081875170C17744445 @default.
• W3081875170 hasConceptScore W3081875170C191935318 @default.

• next